Download PDF
1 / Pages

Other users also viewed these articles

Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies Paloma de Abreu; Gabriela Ávila-Pedretti; Zoilo Morel; María Isabel Acosta; Sonia Cabrera-Villalba; Patricia Melgarejo; Marcos Franco; Pedro Delgadillo; Lourdes Román; Juan Gabriel Elizaur; Ernesto Paredes; Darwin Octavio Cordobilla; Daniel Palleiro; Miguel Albanese; Julio Mazzoleni;
Reumatol Clin. 2020;16P2:396-404
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;
Reumatol Clin. 2022;18:188-9
Clinical management and discontinuation of treatment in patients with recent onset rheumatoid arthritis in a rheumatology consultation Zulema Rosales Rosado; Judit Font Urgelles; Isabel Hernández Rodríguez; Leticia León Mateos; Lydia Abásolo Alcázar; Juan Ángel Jover Jover;
Reumatol Clin. 2022;18:77-83